• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Comparison of patient and technique survival in continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis: a multicenter study.

作者信息

Serkes K D, Blagg C R, Nolph K D, Vonesh E F, Shapiro F

机构信息

Baxter Healthcare Corporation, Round Lake, IL 60073.

出版信息

Perit Dial Int. 1990;10(1):15-9.

PMID:2085575
Abstract

Patient and technique survival were compared in adult patients new to continuous ambulatory peritoneal dialysis (CAPD) or (primarily) center hemodialysis (HD) in the time period 1981 to 1983, and followed-up in March 1985. Risk factors were identified at entrance into the study, and results were analyzed using Cox's proportional hazards model. For nondiabetic patients, the difference in survival which favored CAPD (relative risk = 0.62) was not significant at the 5% level (p = 0.08). Age was a significant risk factor in both groups. The average number of hospital visits was the same; however, CAPD showed a small but significant increase in average annual hospital days per year (10.14 vs. 9.18). For diabetic patients, there was no significant difference in survival between CAPD and HD. The CAPD group showed a significant increase in hospital visits (relative risk 1.81 vs. 1.40) and average hospital days per year (19.43 vs. 13.41). Both CAPD groups showed significantly higher treatment changeover rates.

摘要

相似文献

1
Comparison of patient and technique survival in continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis: a multicenter study.
Perit Dial Int. 1990;10(1):15-9.
2
A multicenter, selection-adjusted comparison of patient and technique survivals on CAPD and hemodialysis.
Perit Dial Int. 1991;11(2):118-27.
3
Dialysis in patients with diabetic nephropathy: CAPD versus hemodialysis.糖尿病肾病患者的透析:持续性非卧床腹膜透析与血液透析
Perit Dial Int. 1996;16 Suppl 1:S269-74.
4
Mortality risks of peritoneal dialysis and hemodialysis.腹膜透析和血液透析的死亡风险。
Am J Kidney Dis. 1999 Dec;34(6):1065-74. doi: 10.1016/S0272-6386(99)70012-0.
5
Comparison of survival in CAPD and hemodialysis: a multicenter study.持续性非卧床腹膜透析与血液透析生存率的比较:一项多中心研究。
Adv Perit Dial. 1992;8:136-40.
6
Comparison of continuous ambulatory peritoneal dialysis and hemodialysis patient survival with evaluation of trends during the 1980s.持续性非卧床腹膜透析与血液透析患者生存率的比较及20世纪80年代趋势评估
J Am Soc Nephrol. 1992 Nov;3(5):1147-55. doi: 10.1681/ASN.V351147.
7
Survival comparison between hemodialysis and peritoneal dialysis based on matched doses of delivered therapy.基于匹配的治疗剂量对血液透析和腹膜透析的生存情况进行比较。
J Am Soc Nephrol. 2002 Jan;13 Suppl 1:S48-52.
8
Long-term survival on peritoneal dialysis in end-stage renal disease owing to diabetes.糖尿病所致终末期肾病患者腹膜透析的长期生存情况
Adv Perit Dial. 2000;16:59-66.
9
Continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis: pride and prejudice.持续性非卧床腹膜透析(CAPD)与血液透析:骄傲与偏见。
Perit Dial Int. 1990;10(1):5-7.
10
Comparison of long-term survival between hemodialysis and peritoneal dialysis.血液透析与腹膜透析的长期生存率比较。
Adv Perit Dial. 1996;12:79-88.

引用本文的文献

1
A comprehensive review on advancements in tissue engineering and microfluidics toward kidney-on-chip.关于组织工程和微流控技术在肾芯片方面进展的综合综述。
Biomicrofluidics. 2022 Aug 16;16(4):041501. doi: 10.1063/5.0087852. eCollection 2022 Jul.
2
Peritoneal Dialysis Modality Failure in a Middle-Income Country: A Retrospective Cohort Study.中等收入国家的腹膜透析模式失败:一项回顾性队列研究
Kidney Med. 2021 Feb 17;3(3):335-342.e1. doi: 10.1016/j.xkme.2020.12.010. eCollection 2021 May-Jun.
3
Hospitalization for Patients on Combination Therapy With Peritoneal Dialysis and Hemodialysis Compared With Hemodialysis.
接受腹膜透析和血液透析联合治疗的患者与仅接受血液透析的患者的住院情况比较
Kidney Int Rep. 2020 Jan 23;5(4):468-474. doi: 10.1016/j.ekir.2020.01.004. eCollection 2020 Apr.
4
The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS): Unifying Efforts to Inform Practice and Improve Global Outcomes in Peritoneal Dialysis.腹膜透析结局与实践模式研究(PDOPPS):统一各方力量,为腹膜透析实践提供信息并改善全球治疗结局
Perit Dial Int. 2016 May-Jun;36(3):297-307. doi: 10.3747/pdi.2014.00288. Epub 2015 Nov 2.
5
Peritoneal Dialysis as a First versus Second Option after Previous Haemodialysis: A Very Long-Term Assessment.腹膜透析作为既往血液透析后的首选与次选方案:一项长期评估
Int J Nephrol. 2014;2014:693670. doi: 10.1155/2014/693670. Epub 2014 Nov 20.
6
Peritoneal dialysis: update on patient survival.腹膜透析:患者生存情况的最新进展
Clin Nephrol. 2015 Jan;83(1):1-10. doi: 10.5414/CN108382.
7
Peritoneal dialysis outcomes of Indigenous Australian patients of remote Kimberley origin.来自偏远金伯利地区的澳大利亚原住民患者的腹膜透析治疗结果。
Aust J Rural Health. 2014 Jun;22(3):101-8. doi: 10.1111/ajr.12086.
8
Impact of modality choice on rates of hospitalization in patients eligible for both peritoneal dialysis and hemodialysis.对于适合腹膜透析和血液透析的患者,治疗方式的选择对住院率的影响。
Perit Dial Int. 2014 Jan-Feb;34(1):41-8. doi: 10.3747/pdi.2012.00257.
9
The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial.低糖降解产物、中性 pH 值与标准腹膜透析液对腹膜功能影响的研究:balANZ 试验。
Nephrol Dial Transplant. 2012 Dec;27(12):4445-53. doi: 10.1093/ndt/gfs314. Epub 2012 Aug 1.
10
Changes in patient and technique survival over time among incident peritoneal dialysis patients in Canada.加拿大新置腹膜透析患者的患者和技术生存率随时间的变化。
Clin J Am Soc Nephrol. 2012 Jul;7(7):1145-54. doi: 10.2215/CJN.01480212. Epub 2012 May 3.